(Q38582633)

English

A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.

scientific article published on 07 September 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

0 references

A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

0 references

3

0 references

5

object named as

Nathan Ford

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

author name string

Katharina Kranzer

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Wael F Elamin

2

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Francis Drobniewski

6

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

language of work or name

0 references

publication date

7 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1070-1077

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Polyamine-like actions of aminoglycosides and aminoglycoside derivatives at NMDA receptors

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Calcium imaging in gentamicin ototoxicity: increased intracellular calcium relates to oxidative stress and late apoptosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Aminoglycoside-induced ototoxicity

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Permanent gentamicin vestibulotoxicity

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Hearing loss in patients on treatment for drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Auditory research involving antioxidants

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Protection from ototoxicity of intraperitoneal gentamicin in guinea pig.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Aspirin to prevent gentamicin-induced hearing loss

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Dosing study on the effectiveness of salicylate/N-acetylcysteine for prevention of noise-induced hearing loss

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Antioxidant treatment reduces blast-induced cochlear damage and hearing loss

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

N-Acetyl-cysteine against noise-induced temporary threshold shift in male workers

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

The chemistry and biological activities of N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Adverse reactions associated with acetylcysteine

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Systematic review of N-acetylcysteine in the treatment of addictions

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Antioxidant therapy in hemodialysis patients: a systematic review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

The promise of N-acetylcysteine in neuropsychiatry

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Mood disorders and complementary and alternative medicine: a literature review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Transformations Related to the Angular and the Square Root

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Principles for designing future regimens for multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-207245

21 January 2018

Identifiers

10.1136/THORAXJNL-2015-207245

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38582633&oldid=1720431579"